Precision BioSciences Statistics
Total Valuation
DTIL has a market cap or net worth of $72.37 million. The enterprise value is $55.92 million.
Important Dates
The last earnings date was Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DTIL has 11.79 million shares outstanding. The number of shares has increased by 68.98% in one year.
| Current Share Class | 11.79M |
| Shares Outstanding | 11.79M |
| Shares Change (YoY) | +68.98% |
| Shares Change (QoQ) | +6.99% |
| Owned by Insiders (%) | 7.09% |
| Owned by Institutions (%) | 45.96% |
| Float | 10.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 92.71 |
| Forward PS | n/a |
| PB Ratio | 4.68 |
| P/TBV Ratio | 4.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 80.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.75.
| Current Ratio | 3.45 |
| Quick Ratio | 2.99 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.05 |
Financial Efficiency
Return on equity (ROE) is -205.16% and return on invested capital (ROIC) is -79.38%.
| Return on Equity (ROE) | -205.16% |
| Return on Assets (ROA) | -45.34% |
| Return on Invested Capital (ROIC) | -79.38% |
| Return on Capital Employed (ROCE) | -113.99% |
| Revenue Per Employee | $6,463 |
| Profits Per Employee | -$774,093 |
| Employee Count | 108 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.90% in the last 52 weeks. The beta is 1.09, so DTIL's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -26.90% |
| 50-Day Moving Average | 5.87 |
| 200-Day Moving Average | 5.17 |
| Relative Strength Index (RSI) | 43.32 |
| Average Volume (20 Days) | 188,610 |
Short Selling Information
The latest short interest is 463,970, so 3.94% of the outstanding shares have been sold short.
| Short Interest | 463,970 |
| Short Previous Month | 1.14M |
| Short % of Shares Out | 3.94% |
| Short % of Float | 4.40% |
| Short Ratio (days to cover) | 4.88 |
Income Statement
In the last 12 months, DTIL had revenue of $698,000 and -$83.60 million in losses. Loss per share was -$8.32.
| Revenue | 698,000 |
| Gross Profit | 698,000 |
| Operating Income | -89.50M |
| Pretax Income | -83.60M |
| Net Income | -83.60M |
| EBITDA | -87.93M |
| EBIT | -89.50M |
| Loss Per Share | -$8.32 |
Full Income StatementBalance Sheet
The company has $44.87 million in cash and $29.13 million in debt, giving a net cash position of $15.74 million or $1.34 per share.
| Cash & Cash Equivalents | 44.87M |
| Total Debt | 29.13M |
| Net Cash | 15.74M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 16.63M |
| Book Value Per Share | 1.38 |
| Working Capital | 36.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.28 million and capital expenditures -$163,000, giving a free cash flow of -$73.44 million.
| Operating Cash Flow | -73.28M |
| Capital Expenditures | -163,000 |
| Free Cash Flow | -73.44M |
| FCF Per Share | -$6.23 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -12,822.64% |
| Pretax Margin | -11,977.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DTIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -68.98% |
| Shareholder Yield | -68.98% |
| Earnings Yield | -116.66% |
| FCF Yield | -102.48% |
Analyst Forecast
The average price target for DTIL is $47.00, which is 665.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.00 |
| Price Target Difference | 665.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -5.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 14, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Feb 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
